S-4 Filing

The SPAC held about $225 million in trust as of April, when the SPAC signed an LOI with HDL Therapeutics, a privately held commercial stage biotech company. Based on that amount, redemptions erased about 95% of the trust.

The transaction would give Allrites an enterprise value of $92 million on a pro forma basis.

Healthcare AI Acquisition raised $200 million in a December 2021 IPO. The company has been focused on businesses in the healthcare and pharmaceutical industry.

The SPAC raised $110 million in an October 2021 IPO with initial plans to focus on targets in the healthcare industry.

The SPAC has a merger agreement with Bestpath (Shanghai) IoT Technology Co., Ltd. Bestpath develops hydrogen fuel cell powered vehicles in China.

Announced in November, the transaction includes a $30 million fully committed common stock PIPE. In addition, Mobix Labs has signed a non-binding term sheet with B. Riley Principal Capital for a $100 million equity line of credit.

The SPAC has an LOI with Cyclebit Group, a global payments and SaaS provider

Viveon had about $20 million on hand when the merger agreement was announced. The SPAC raised $201.25 million in a December 2020 IPO, although redemptions since then have carved out the trust. 

The SPAC raised $86.25 million in a January 2022 IPO with a focus on the neuro-musculoskeletal industry.

Blue Ocean raised $165 million in December 2021 with plans to search for a target business in the digital media and consumer internet industries.